Aligos Therapeutics Inc (ALGS)
0.685
+0.03
(+4.58%)
USD |
NASDAQ |
May 17, 16:00
0.685
0.00 (0.00%)
Pre-Market: 20:00
Aligos Therapeutics Price to Book Value: 0.8994 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 0.8994 |
| May 16, 2024 | 0.8556 |
| May 15, 2024 | 0.8871 |
| May 14, 2024 | 0.9033 |
| May 13, 2024 | 0.8943 |
| May 10, 2024 | 0.954 |
| May 09, 2024 | 1.014 |
| May 08, 2024 | 1.023 |
| May 07, 2024 | 1.032 |
| May 06, 2024 | 1.058 |
| May 03, 2024 | 1.058 |
| May 02, 2024 | 1.105 |
| May 01, 2024 | 1.006 |
| April 30, 2024 | 0.9993 |
| April 29, 2024 | 0.9585 |
| April 26, 2024 | 1.03 |
| April 25, 2024 | 1.077 |
| April 24, 2024 | 1.092 |
| April 23, 2024 | 1.085 |
| April 22, 2024 | 1.055 |
| April 19, 2024 | 0.9879 |
| April 18, 2024 | 1.045 |
| April 17, 2024 | 1.037 |
| April 16, 2024 | 1.100 |
| April 15, 2024 | 1.178 |
| Date | Value |
|---|---|
| April 12, 2024 | 1.317 |
| April 11, 2024 | 1.396 |
| April 10, 2024 | 1.370 |
| April 09, 2024 | 1.396 |
| April 08, 2024 | 1.409 |
| April 05, 2024 | 1.370 |
| April 04, 2024 | 1.281 |
| April 03, 2024 | 1.330 |
| April 02, 2024 | 1.288 |
| April 01, 2024 | 1.253 |
| March 31, 2024 | |
| March 28, 2024 | 0.8053 |
| March 27, 2024 | 0.8045 |
| March 26, 2024 | 0.8382 |
| March 25, 2024 | 0.7714 |
| March 22, 2024 | 0.8136 |
| March 21, 2024 | 0.7807 |
| March 20, 2024 | 0.7831 |
| March 19, 2024 | 0.7656 |
| March 18, 2024 | 0.756 |
| March 15, 2024 | 0.7573 |
| March 14, 2024 | 0.7147 |
| March 13, 2024 | 0.7149 |
| March 12, 2024 | 0.7149 |
| March 11, 2024 | 0.7232 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.2904
Minimum
May 06 2022
6.567
Maximum
Jun 11 2021
1.63
Average
0.6367
Median
Price to Book Value Benchmarks
| Mirum Pharmaceuticals Inc | 4.836 |
| CEL-SCI Corp | 4.808 |
| AIM ImmunoTech Inc | 2.107 |
| IGC Pharma Inc | 3.942 |
| NovaBay Pharmaceuticals Inc | -- |
Price to Book Value Related Metrics
| PS Ratio | 3.968 |
| Price | 0.685 |
| Earnings Yield | -207.9% |
| Market Cap | 53.78M |